Allergan Aesthetics Unveils Evolving Trends in Medical Weight Loss Treatments and Patient Profiles

In a groundbreaking disclosure, Allergan Aesthetics, an AbbVie company, recently shared insightful data regarding the rising trends in Medical Weight Loss (MWL) treatments, emphasizing the evolving profile of patients seeking these services. As societal norms shift and the aesthetics landscape evolves, the demand for MWL treatments is experiencing notable changes that are reshaping patient expectations and treatment approaches.

A Shift in Patient Landscape

The data showcases a significant transformation in patient behaviors and preferences. Notably, 67% of patients expressed that their goals have shifted from mere weight reduction to enhancing overall appearance. This suggests a growing number of patients now view MWL treatments through a broader aesthetic lens.

Not only are patients focusing on weight loss; they are also considering the visible implications of weight fluctuations on their facial appearance. Nearly 47% of MWL patients indicated a high benefit from using hyaluronic acid injectable fillers, particularly when addressing concerns related to facial volume loss post-weight loss.

The connection between aesthetic treatments and weight loss medications is also apparent. Recent statistics reveal that 60% of patients utilizing GLP-1 medications to assist weight loss are now receiving these treatments from providers who also offer aesthetic options—a notable increase from 49% recorded in late 2024. This highlights an important trend in patient care, where patients are inclined to seek comprehensive aesthetics services in tandem with medical weight management solutions.

Understanding Patient Needs

As patients embark on their weight loss journeys, they are met with distinctive challenges that influence their aesthetic desires. Allergan's Senior Vice President, Glen Curran, acknowledges these shifts, emphasizing the importance of personalized, long-term aesthetic care. With facial structure, volume, and skin quality becoming significant concerns, early consultation and tailored treatment plans are critical in aiding patients to achieve balanced outcomes. This evolution calls for aesthetic practitioners to adapt and respond to new patient needs promptly.

Interestingly, the rising consumer interest in aesthetics is evident: 40% of MWL patients are contemplating professional aesthetic treatments within medical frameworks, such as physician’s offices and medspas. This trend evidences a shift in patient behavior—patients are not merely focused on losing weight but also on rejuvenating their appearances as they reach their weight loss goals.

Aesthetic Changes Post-Weight Loss

The face often reflects the changes brought about by significant weight loss, with 61% of patients on GLP-1 medications reporting midface volume reduction, 50% citing skin laxity, and 35% experiencing worsening facial wrinkles or folds. These revelations underline the necessity for comprehensive care that embraces both weight management and aesthetic enhancement simultaneously.

To address these prevalent concerns, hyaluronic acid dermal fillers emerge as a preferred, non-surgical solution. Studies suggest that 81% of healthcare providers consider HA fillers vital in addressing volume loss related to weight loss. Furthermore, one-third of practitioners acknowledge that the advent of GLP-1 drug usage has notably increased the overall volume of dermal filler injections they administer in practice. This emphasizes the rising opportunity within the aesthetic sector to cater to this new wave of patients.

Expert Insights and Future Directions

Dr. Joely Kaufman, a board-certified dermatologist based in Miami, confirms these findings, noting firsthand how medical weight loss significantly alters patients’ facial aesthetics. The data shared by Allergan resonates with trends observed in practices nationwide, where patients express enthusiasm for their weight loss successes and seek medical solutions that restore their facial balance and confidence.

Allergan Aesthetics has been active in researching the confluence of MWL and aesthetic medicine since early 2022. Their findings have been shared at various esteemed medical forums, including the 2025 American Society for Dermatologic Surgery (ASDS) Annual Meeting, reinforcing the emerging needs of patients seeking physician-led aesthetic solutions following weight loss.

With a commitment to understanding these trends, Allergan Aesthetics aims to provide innovative, personalized aesthetic solutions that align with the evolving needs of today’s patients. This comprehensive approach promises to redefine patient experiences in the realm of health and aesthetics.

For those seeking to explore more about MWL and its implications on aesthetics, Allergan encourages accessing their detailed infographics and resources available on their official website. This initiative positions Allergan Aesthetics not just as a provider of products, but as a pioneer in addressing the holistic concerns of modern patients navigating their transformation journeys.